3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine is a pharmaceutical intermediate used in the synthesis of sitagliptin.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 486460-21-3
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
pharmaceutical intermediate
Tert-Butyl [(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]carbamate
pharmaceutical intermediate
2-(1,2-benzoxazol-3-yl)ethanoic acid
pharmaceutical intermediate
(+)-pinoresinol
pharmaceutical intermediate
(2S,4S)-4-Cyano-1,2-pyrrolidinedicarboxylic acid 1-(tert-butyl) 2-methyl ester
pharmaceutical intermediate
Maupiti Airport
pharmaceutical intermediate
3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
FMTDZGCPYKWMPT-UHFFFAOYSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1
—